High Prevalence of Radiological Vertebral Fractures in Women on Thyroid-Stimulating Hormone–Suppressive Therapy for Thyroid Carcinoma
Author(s) -
Gherardo Mazziotti,
Anna Maria Formenti,
Stefano Frara,
Roberto Olivetti,
Giuseppe Banfi,
Maurizio Memo,
Roberto Maroldi,
Raffaele Giubbini,
Andrea Giustina
Publication year - 2017
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2017-01986
Subject(s) - medicine , osteopenia , osteoporosis , bone mineral , femoral neck , bone density , thyroid , bone remodeling , thyroid carcinoma , endocrinology , population , gastroenterology , urology , environmental health
Bone loss and nonvertebral fractures have been reported in patients with differentiated thyroid carcinoma (DTC) undergoing thyroid-stimulating hormone (TSH) suppressive therapy. Radiological vertebral fractures (VFs) are an early and clinically crucial marker of bone fragility.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom